| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
1,529 |
1,255 |
$104K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,090 |
1,837 |
$100K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
1,040 |
892 |
$79K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
382 |
339 |
$28K |
| 90686 |
|
657 |
567 |
$8K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
297 |
272 |
$8K |
| 90670 |
|
588 |
515 |
$7K |
| 90723 |
|
474 |
411 |
$7K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
88 |
79 |
$7K |
| 90647 |
|
440 |
387 |
$6K |
| 90677 |
|
233 |
215 |
$5K |
| 83655 |
|
337 |
243 |
$4K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
24 |
18 |
$3K |
| 96127 |
|
166 |
144 |
$2K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
25 |
25 |
$2K |
| 90633 |
|
119 |
92 |
$1K |
| 90681 |
|
79 |
70 |
$1K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
29 |
27 |
$1K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
20 |
18 |
$1K |
| 36416 |
|
113 |
92 |
$401.80 |
| 90381 |
|
17 |
16 |
$284.07 |
| 85018 |
|
46 |
28 |
$106.72 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
12 |
12 |
$0.00 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
19 |
14 |
$0.00 |